The PI3K/Akt/mTOR pathway is activated in murine lupus nephritis and downregulated by rapamycin K Stylianou, I Petrakis, V Mavroeidi, S Stratakis, E Vardaki, K Perakis, ... Nephrology Dialysis Transplantation 26 (2), 498-508, 2011 | 131 | 2011 |
Low serum testosterone, arterial stiffness and mortality in male haemodialysis patients J Kyriazis, I Tzanakis, K Stylianou, I Katsipi, D Moisiadis, A Papadaki, ... Nephrology Dialysis Transplantation 26 (9), 2971-2977, 2011 | 107 | 2011 |
Histopathological, immunohistochemical, genetic and molecular markers of neuroendocrine neoplasms G Kyriakopoulos, V Mavroeidi, E Chatzellis, GA Kaltsas, KI Alexandraki Annals of translational medicine 6 (12), 2018 | 90 | 2018 |
Long‐term complication rates and survival of peritoneal dialysis catheters: the role of percutaneous versus surgical placement KE Perakis, KG Stylianou, JP Kyriazis, VN Mavroeidi, IG Katsipi, ... Seminars in dialysis 22 (5), 569-575, 2009 | 55 | 2009 |
Losartan affects glomerular AKT and mTOR phosphorylation in an experimental model of type 1 diabetic nephropathy V Mavroeidi, I Petrakis, K Stylianou, T Katsarou, K Giannakakis, K Perakis, ... Journal of Histochemistry & Cytochemistry 61 (6), 433-443, 2013 | 36 | 2013 |
Rapamycin ameliorates proteinuria and restores nephrin and podocin expression in experimental membranous nephropathy S Stratakis, K Stylianou, I Petrakis, V Mavroeidi, R Poulidaki, C Petra, ... Journal of Immunology Research 2013 (1), 941893, 2013 | 18 | 2013 |
Biopsy-proven resolution of renal light-chain deposition disease after autologous stem cell transplantation I Petrakis, K Stylianou, V Mavroeidi, E Vardaki, S Stratigis, S Stratakis, ... Nephrology Dialysis Transplantation 25 (6), 2020-2023, 2010 | 18 | 2010 |
Rapamycin induced ultrastructural and molecular alterations in glomerular podocytes in healthy mice K Stylianou, I Petrakis, V Mavroeidi, S Stratakis, G Kokologiannakis, ... Nephrology Dialysis Transplantation 27 (8), 3141-3148, 2012 | 16 | 2012 |
Distinctive features of pancreatic neuroendocrine neoplasms exhibiting an increment in proliferative activity during the course of the disease KI Alexandraki, M Kaltsatou, G Kyriakopoulos, V Mavroeidi, ... Endocrine 72, 279-286, 2021 | 13 | 2021 |
Membranous nephropathy and lupus-like syndrome after hematopoietic cell transplantation: a case report K Stylianou, S Stratakis, V Mavroeidi, I Petrakis, D Xydakis, E Vardaki, ... Journal of Medical Case Reports 4, 1-4, 2010 | 11 | 2010 |
Role of receptor profiling for personalized therapy in a patient with a growth hormone-secreting macroadenoma resistant to first-generation somatostatin analogues KI Alexandraki, E Papadimitriou, V Mavroeidi, G Kyriakopoulos, A Xydakis, ... Journal of Personalized Medicine 9 (4), 48, 2019 | 5 | 2019 |
Hsf-1 affects podocyte markers NPHS1, NPHS2 and WT1 in a transgenic mouse model of TTRVal30Met-related amyloidosis I Petrakis, V Mavroeidi, K Stylianou, E Andronikidi, E Lioudaki, K Perakis, ... Amyloid 20 (3), 164-172, 2013 | 4 | 2013 |
Human TTRV30M localization within podocytes in a transgenic mouse model of transthyretin related amyloidosis: does the environment play a role? I Petrakis, V Mavroeidi, K Stylianou, G Efthymiou, K Perakis, E Vardaki, ... Transgenic research 22, 101-116, 2013 | 4 | 2013 |
Thyroid autoimmunity has no negative impact on insulin dynamics in pre-diabetic patients with normal thyroid function K Alexandraki, G Boutzios, I Antonopoulou, LI Bartsioka, P Moschouris, ... | 2 | 2020 |
Immunohistochemical expression of ephrines A2 and A4 receptors in neuroendocrine neoplasms: preliminary results K Alexandraki, I Antonopoulou, M Karaflou, C Christakou, V Mavroeidi, ... Endocrine Abstracts 63, 2019 | 2 | 2019 |
3β-Hydroxysteroid Dehydrogenase Type 2 (3βHSD2) deficiency due to a novel compound heterozygosity of a missense mutation (p. Thr259Met) and frameshift deletion (p. Lys273ArgFs … S Leka-Emiri, L Taibi, V Mavroeidi, EA Vlachopapadopoulou, M Kafetzi, ... Sexual Development 16 (1), 64-69, 2022 | 1 | 2022 |
The role of leptin in nutritional status and survival in chronic kidney disease (CKD) patients A Markaki, I Petrakis, V Mavroeidi, K Perakis, G Fragkiadakis, M Venyhaki, ... Nephrol Dial Transplant 27, 2012 | 1 | 2012 |
Blocking glomerular immunoglobulin deposits in a mouse model of lupus nephritis on indirect immunofluorescence with the use of Fab fragments I Petrakis, V Mavroeidi, K Stylianou, K Giannakakis, E Daphnis Journal of immunological methods 376 (1-2), 139-142, 2012 | 1 | 2012 |
Intermittent peritoneal dialysis a disregarded therapy for disadvantaged patients IG Petrakis, VN Mavroeidi, SI Stratakis, KE Perakis, EA Vardaki, ... Clinical Nephrology 74, S170-S171, 2010 | 1 | 2010 |
Pitfall in the Diagnosis of an Aggressive Adrenal Mass with Prominent Hirsutism: A Case Report A Markou, L Papanastasiou, A Dimitriadi, V Mavroeidi, C Aggeli, ... Eurasian Journal of Medicine and Oncology 6 (2), 186, 2022 | | 2022 |